These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32306660)

  • 21. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery.
    Yang XY; Wu B; Ma SL; Yin L; Wu MC; Li AJ
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818794190. PubMed ID: 30198401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.
    Zhang G; Liu T; Wang Z
    J Invest Surg; 2012 Apr; 25(2):93-9. PubMed ID: 21942217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression tendency and prognostic value of TCF21 in hepatocellular carcinoma.
    Lu W; Yang C; Du P; Zhang JL; Zhang JC
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1466-1470. PubMed ID: 31014118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
    Tian YW; Shen Q; Jiang QF; Wang YX; Li K; Xue HZ
    Minerva Med; 2017 Apr; 108(2):108-113. PubMed ID: 27879964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnostic and prognostic value of H2AFY in hepatocellular carcinoma.
    Ma X; Ding Y; Zeng L
    BMC Cancer; 2021 Apr; 21(1):418. PubMed ID: 33858382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [High expression of miR-3682-3p is an unfavorable prognostic factor of hepatocellular carcinoma].
    Liu S; Wen Y; Quan B; Lin J; Zhu Z; Tang J; Han S
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Dec; 41(12):1885-1891. PubMed ID: 35012923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential effects of Mina53 on tumor growth in human pancreatic cancer.
    Tan XP; Dong WG; Zhang Q; Yang ZR; Lei XF; Ai MH
    Cell Biochem Biophys; 2014 Jul; 69(3):619-25. PubMed ID: 24522517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma.
    Ishizaki H; Yano H; Tsuneoka M; Ogasawara S; Akiba J; Nishida N; Kojiro S; Fukahori S; Moriya F; Matsuoka K; Kojiro M
    Pathol Int; 2007 Oct; 57(10):672-80. PubMed ID: 17803656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Mina53, a novel c-Myc target gene, is a favorable prognostic marker in early stage lung cancer.
    Komiya K; Sueoka-Aragane N; Sato A; Hisatomi T; Sakuragi T; Mitsuoka M; Sato T; Hayashi S; Izumi H; Tsuneoka M; Sueoka E
    Lung Cancer; 2010 Aug; 69(2):232-8. PubMed ID: 19914733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
    Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
    Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
    Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
    Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of long noncoding RNA AK021443 predicts worse clinical outcome in hepatocellular carcinoma.
    Li YC; Wang D; Zhu GY
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4855-4860. PubMed ID: 30070318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
    Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
    Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NDRG3 overexpression is associated with a poor prognosis in patients with hepatocellular carcinoma.
    Jing JS; Li H; Wang SC; Ma JM; Yu LQ; Zhou H
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
    Wu S; Chen X; Hu C; Wang J; Shen Y; Zhong Z
    Med Sci Monit; 2017 Dec; 23():5705-5713. PubMed ID: 29192136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mina53, a novel molecular marker for the diagnosis and prognosis of gastric adenocarcinoma.
    Xing J; Wang K; Liu PW; Miao Q; Chen XY
    Oncol Rep; 2014 Feb; 31(2):634-40. PubMed ID: 24337011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.